“…For GluN1/GluN2B receptors, ifenprodil and Ro 25-6881 antagonists are selective negative allosteric modulators that bind to the extracellular N-terminal domains (Hatton and Paoletti, 2005). Some studies have reported block of LTD by ifenprodil or Ro 25-6981 (Liu et al, 2004;Massey et al, 2004;Fox et al, 2006;Izumi et al, 2006;Gerkin et al, 2007;Ge et al, 2010;Dong et al, 2013;Izumi and Zorumski, 2015;Mizui et al, 2015;Yasuda and Mukai, 2015), though others report no effect (Hendricson et al, 2002;Bartlett et al, 2007;Li et al, 2007;Morishita et al, 2007;Kollen et al, 2008;Hanson et al, 2015;Yasuda and Mukai, 2015). However, these inhibitors display partial activitydependence and only block a fraction (~80%) of synaptic GluN1/GluN2B diheteromers (Fischer et al, 1997;Hatton and Paoletti, 2005;Gray et al, 2011), which could result in variable effects based on drug concentration, slice activity, and pre-incubation time.…”